| 1 |
34952963 | Effects of CYP2C9*3 and *13 alleles on the pharmacokinetics and pharmacodynamics of glipizide in healthy Korean subjects. | 2022 Feb |
6 |
| 2 |
31709648 | The presence of two reduced function variants in CYP2C9 influences the acute response to glipizide. | 2020 Dec |
2 |
| 3 |
30584236 | OATP1B3 (699G>A) and CYP2C9*2, *3 significantly influenced the transport and metabolism of glibenclamide and glipizide. | 2018 Dec 24 |
5 |
| 4 |
28284082 | Simultaneous determination of glipizide and its four hydroxylated metabolites in human urine using LC-MS/MS and its application in urinary phenotype study. | 2017 May 30 |
2 |
| 5 |
24799741 | Investigating the Role of Plasma Glucose Concentration as a Phenotypic Marker for CYP2C9 Genetic Variants, in the Diabetic Population of Gujarat. | 2014 Jan |
3 |
| 6 |
21182487 | Clinical drugs undergoing polymorphic metabolism by human cytochrome P450 2C9 and the implication in drug development. | 2011 |
1 |
| 7 |
19847408 | The effects of CYP2C9 and CYP2C19 genetic polymorphisms on the pharmacokinetics and pharmacodynamics of glipizide in Chinese subjects. | 2010 Feb |
3 |
| 8 |
20698928 | Potential CYP2C9-mediated drug-drug interactions in hospitalized type 2 diabetes mellitus patients treated with the sulphonylureas glibenclamide, glimepiride or glipizide. | 2010 Oct |
5 |
| 9 |
16372821 | Effect of genetic polymorphisms in cytochrome p450 (CYP) 2C9 and CYP2C8 on the pharmacokinetics of oral antidiabetic drugs: clinical relevance. | 2005 |
1 |
| 10 |
14600250 | Induction of human CYP2C9 by rifampicin, hyperforin, and phenobarbital is mediated by the pregnane X receptor. | 2004 Feb |
1 |
| 11 |
11406737 | Effects of rifampin on the pharmacokinetics and pharmacodynamics of glyburide and glipizide. | 2001 Jun |
1 |
| 12 |
11740344 | Identification of a null allele of CYP2C9 in an African-American exhibiting toxicity to phenytoin. | 2001 Dec |
2 |
| 13 |
10208645 | Pharmacokinetics of chlorpheniramine, phenytoin, glipizide and nifedipine in an individual homozygous for the CYP2C9*3 allele. | 1999 Feb |
2 |